Advances in Engineered Heart Tissue for Heart Disease Treatment
Author Information
Author(s): He Xingyu, Good Angela, Kalou Wael, Ahmad Waqas, Dutta Suchandrima, Chen Sophie, Lin Charles Noah, Chella Krishnan Karthickeyan, Fan Yanbo, Huang Wei, Liang Jialiang, Wang Yigang
Primary Institution: University of Cincinnati
Hypothesis
Can engineered heart tissue derived from pluripotent stem cells effectively treat cardiovascular diseases?
Conclusion
Engineered heart tissue shows promise in regenerating damaged heart tissue and improving cardiac function in preclinical and early clinical studies.
Supporting Evidence
- Engineered heart tissue can integrate with host myocardium and improve cardiac function.
- Preclinical studies show that engineered heart tissue can reduce scar tissue and enhance heart function metrics.
- Clinical trials are exploring the safety and feasibility of engineered heart tissue in humans.
Takeaway
Scientists are creating new heart tissue from stem cells to help fix damaged hearts, which could be better than current treatments.
Methodology
This review discusses advancements in engineered heart tissue, focusing on materials, fabrication methods, and therapeutic potential.
Limitations
Challenges include immune rejection, vascularization, and scalability of engineered heart tissue.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website